🔗 Share this article

Texas Attorney General Paxton is suing the manufacturers of Tylenol, asserting the corporations concealed potential risks that the drug created to pediatric neurological development.

The court filing comes thirty days after President Donald Trump publicized an unsubstantiated connection between taking Tylenol - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.

Paxton is filing suit against J&J, which once produced the medication, the only pain reliever suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "betrayed America by gaining financially from suffering and pushing pills regardless of the potential hazards."

The manufacturer says there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies deceived for years, intentionally threatening countless individuals to line their pockets," the attorney general, from the Republican party, said.

Kenvue said in a statement that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the health of American women and children."

On its official site, Kenvue also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a verified association between taking acetaminophen and autism."

Groups representing doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in acetaminophen - is a restricted selection for expectant mothers to address discomfort and fever, which can create major wellness concerns if ignored.

"In multiple decades of research on the utilization of acetaminophen in gestation, not a single reputable study has successfully concluded that the use of paracetamol in any period of gestation causes neurodevelopmental disorders in young ones," the association said.

The court filing mentions latest statements from the former administration in arguing the medication is potentially dangerous.

Last month, the former president caused concern from health experts when he instructed women during pregnancy to "struggle intensely" not to consume Tylenol when unwell.

Federal regulators then published an announcement that medical professionals should think about restricting the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in children has remains unverified.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in spring to undertake "a massive testing and research effort" that would establish the origin of autism in a limited time.

But authorities advised that finding a single cause of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and condition that impacts how people perceive and engage with the environment, and is diagnosed using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "willfully ignored and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

The case seeks to make the corporations "eliminate any promotional materials" that asserts acetaminophen is secure for pregnant women.

The court case mirrors the complaints of a assembly of guardians of minors with autism and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in two years ago.

The court dismissed the case, stating studies from the parents' expert witnesses was lacking definitive proof.